Stock 688238 OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Obio Technology (Shanghai) Corp., Ltd.

Equities

688238

CNE1000059N9

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
5.74 CNY +1.06% Intraday chart for Obio Technology (Shanghai) Corp., Ltd. -7.42% -36.15%
05-16 Obio Technology's Shareholders to Offload Up to 1.5% Stake MT
04-28 Obio Technology Corp., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

OBio Technology Shanghai Corp Ltd is a China-based company mainly engaged in the research and development and production of recombinant viruses for gene therapy. The Company is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The Company mainly conducts business in the European and American markets and the domestic market.

Number of employees: 731

Sales per Business

CNY in Million2022Weight2023Weight Delta
Gene Therapy Contract Development and Manufacturing Organization
52.2 %
217 74.4 % 107 52.2 % -50.64%
Gene Therapy Contract Research Organization
38.8 %
66 22.6 % 79 38.8 % +20.56%
Biological Agents, Reagents and Others
9.0 %
7 2.3 % 18 9.0 % +176.90%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
92.2 %
278 95.3 % 189 92.2 % -32.01%
Other Areas
7.7 %
13 4.3 % 16 7.7 % +24.99%
Overseas
0.2 %
1 0.4 % 0 0.2 % -70.90%

Managers

Managers TitleAgeSince
Guo Dong Jia CEO
 Chief Executive Officer 43 31/01/17
Rui Dong Pan CHM
 Chairman 56 28/02/13
Lu Yuan Xu DFI
 Director of Finance/CFO 54 30/09/16
Zhao Rui Song BRD
 Director/Board Member 49 30/06/21
Jun Yi Pan BRD
 Director/Board Member 30 31/03/17
Fu Jie Wang BRD
 Director/Board Member 49 31/01/14
Shan Yin BRD
 Director/Board Member 42 31/05/13
Wen Zhao IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Shan Yin BRD
 Director/Board Member 42 31/05/13
Rui Dong Pan CHM
 Chairman 56 28/02/13
Guo Dong Jia CEO
 Chief Executive Officer 43 31/01/17
Zheng Qi Song BRD
 Director/Board Member 43 28/12/20
Li Ning Gan BRD
 Director/Board Member 46 28/12/20
Fu Jie Wang BRD
 Director/Board Member 49 31/01/14
Ke Jia Yuan BRD
 Director/Board Member 40 09/10/20
Si Jie Song BRD
 Director/Board Member 29 31/10/18
Xiao Gao CHM
 Chairman 39 29/02/20
Zhao Rui Song BRD
 Director/Board Member 49 30/06/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 647,433,100 418,984,837 ( 64.71 %) 0 64.71 %

Shareholders

NameEquities%Valuation
Shenzhen Yifeng Venture Capital Co. Ltd.
6.091 %
28,429,583 6.091 % 24 M ¥
Shanghai Pudong State-owned Asset Supp & Mgmt Commission
4.971 %
23,200,813 4.971 % 20 M ¥
Sinowisdom Capital Management Co. Ltd.
4.936 %
23,038,080 4.936 % 20 M ¥
Shenzhen Tencent Industrial Investment Fund Co., Ltd.
4.209 %
19,643,000 4.209 % 17 M ¥
Shanghai Jinpu Xinpeng Investment Management Co. Ltd.
2.706 %
12,631,060 2.706 % 11 M ¥
Miao Di Ren
2.549 %
11,897,600 2.549 % 10 M ¥
Yinhua Fund Management Co., Ltd.
0.5358 %
2,500,748 0.5358 % 2 M ¥
China Asset Management Co., Ltd.
0.4001 %
1,867,672 0.4001 % 2 M ¥
GF Fund Management Co., Ltd.
0.2740 %
1,278,835 0.2740 % 1 M ¥
HSBC Jintrust Fund Management Co. Ltd.
0.1843 %
860,230 0.1843 % 732 942 ¥

Company contact information

Obio Technology Shanghai Corp. Ltd.

Building 19, Lane 908 Ziping Road

201318, Shanghai

+

http://www.obiosh.com
address Obio Technology (Shanghai) Corp., Ltd.(688238)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Obio Technology (Shanghai) Corp., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.74 CNY
Average target price
8.2 CNY
Spread / Average Target
+42.86%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
OBIO TECHNOLOGY (SHANGHAI) CORP., LTD. Stock Obio Technology (Shanghai) Corp., Ltd.
-36.15% 515M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688238 Stock
  4. Company Obio Technology (Shanghai) Corp., Ltd.